rs475688 — SLC22A12

SLC22A12 rs475688 — When the Kidney Hoards Uric Acid

Every day, your kidneys filter roughly 7–8 grams of uric acid from your blood. Almost all of it — about 90% — is immediately reabsorbed back into circulation, with just 10% making it into the urine. The protein responsible for most of this reabsorption is URAT1¹¹ URAT1
Urate transporter 1 — an antiporter on the apical membrane of proximal tubule cells; it imports urate into the tubule cell in exchange for organic anions (lactate, nicotinate, pyrazinoate), effectively rescuing urate from the filtrate before it reaches the collecting duct, encoded by SLC22A12. The rs475688 variant sits deep in an intron of this gene, where it acts as an expression switch: the T allele turns URAT1 expression up, producing more transporter protein on the tubule surface and reabsorbing more urate with every liter of filtrate.

The Mechanism

Unlike missense variants that change the URAT1 protein's function, rs475688 changes how much URAT1 is made. A 2025 study in the Journal of Clinical Investigation established rs475688 as a kidney eQTL²² kidney eQTL
expression quantitative trait locus — a genetic variant that alters how strongly a nearby gene is expressed in a specific tissue, measurable by comparing mRNA levels across genotypes in that tissue for SLC22A12 in the renal proximal tubule. Each copy of the T allele adds a measurable increment to SLC22A12 mRNA levels, which translates directly to more URAT1 protein at the tubule surface, higher fractional urate reabsorption, and a raised serum urate setpoint.

The same study revealed an important gene-environment interaction: T carriers show a synergistically amplified urate response to hyperinsulinemia³³ hyperinsulinemia
chronically elevated blood insulin levels, typically seen in insulin resistance, metabolic syndrome, and early type 2 diabetes; insulin independently stimulates URAT1 activity via AKT-mediated phosphorylation of URAT1-Thr408, an effect compounded when more URAT1 protein is available. This means high-carbohydrate diets and insulin resistance can interact multiplicatively with rs475688 to push urate levels well above what either factor would cause alone.

High fructose intake deserves separate mention: fructose metabolism consumes ATP rapidly (generating AMP → IMP → hypoxanthine → xanthine → urate), producing a urate surge that is then retained more efficiently in T allele carriers because URAT1 has a lower renal urate excretion efficiency.

The Evidence

The T allele's effect on urate was quantified at scale in 377,358 UK Biobank participants⁴⁴ 377,358 UK Biobank participants
Hosoyamachi S et al. Gene-environment interaction modifies the association between hyperinsulinemia and serum urate levels through SLC22A12. J Clin Invest, 2025: serum urate rose by 3.58 µmol/L per T allele copy (P = 4.54 × 10⁻⁸⁰), with CC individuals averaging 306.7 µmol/L, CT averaging 309.7 µmol/L, and TT averaging 313.3 µmol/L. This 6.6 µmol/L step from CC to TT is clinically meaningful at the tipping point near the urate supersaturation threshold⁵⁵ supersaturation threshold
Urate becomes sparingly soluble in plasma at approximately 408 µmol/L (6.8 mg/dL) — above this concentration, monosodium urate crystals can nucleate and deposit in joints, tendons, and soft tissues, triggering gout of ~408 µmol/L (6.8 mg/dL).

A meta-analysis of 7 studies⁶⁶ meta-analysis of 7 studies
Zou B et al. Associations between the SLC22A12 gene and gout susceptibility: a meta-analysis. Clin Rheumatol, 2018 (1,216 gout cases, 1,844 controls) found that having at least one risk allele compared to the low-risk homozygote was associated with OR = 2.03 (95% CI 1.49-2.76) for gout. A separate Japanese case-control study⁷⁷ Japanese case-control study
Nakayama A et al. Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk. J Hum Genet, 2016 found that the SLC22A12 risk allele independently predicted gout with OR 1.95 per allele copy, and that risk alleles across ABCG2, SLC2A9, and SLC22A12 compounded in additive fashion — particularly in heavy drinkers, where alcohol metabolism drives both purine production and lactate-mediated URAT1 stimulation.

Population variation in rs475688 is striking: in European and African populations the T allele runs at ~26-32%, while in East Asian populations (Japanese, Korean, Vietnamese) T approaches 50% or higher — the population with the highest gout prevalence globally⁸⁸ highest gout prevalence globally
Gout affects 3-4% of adults in many East Asian countries, compared to 2-3% in Western populations, with male-predominant hyperuricemia rates of 10-30% in Korea and Japan; this excess is multifactorial but URAT1 genetics likely contribute.

Practical Actions

For TT individuals, the urate setpoint is measurably higher and the kidney is working against any dietary effort to lower urate. The most effective strategy is reducing urate production (limit high-purine foods and fructose) while also reducing the competing organic anion substrates that URAT1 uses to cotransport urate (lactate from alcohol, nicotinate from certain supplements). If serum urate is persistently above 6.0 mg/dL despite dietary changes, uricosuric medications — which directly inhibit URAT1 — are the mechanistically appropriate drug class for this genotype.

For CT individuals, the same directional advice applies at lower urgency. Serum urate monitoring and preemptive dietary attention to fructose and purine load are appropriate.

Interactions

The rs475688 interaction with SLC2A9 (rs1079128, rs11942223) is additive: individuals who carry T alleles at both loci have URAT1 overexpression AND GLUT9 overexpression — two complementary reabsorption mechanisms both running hot. ABCG2 (rs2231142) is a urate efflux transporter on the intestinal epithelium; ABCG2 dysfunction and URAT1 overexpression combine to raise serum urate from both ends (reduced gut secretion and increased renal reabsorption).

The insulin-URAT1 pathway (via AKT phosphorylation of URAT1-Thr408) means that metabolic syndrome and insulin resistance are particularly hazardous for T allele carriers — managing blood sugar helps manage urate.